1983
DOI: 10.1016/0024-3205(83)90053-x
|View full text |Cite
|
Sign up to set email alerts
|

Serotonergic and noradrenergic receptors in the rat brain: Modulation by chronic exposure to ovarian hormones

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
72
0
1

Year Published

1989
1989
2008
2008

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 234 publications
(76 citation statements)
references
References 20 publications
3
72
0
1
Order By: Relevance
“…The effect of estradiol to increase 5-HT 2A receptors specific binding of ovariectomized rats was also previously observed using the ligands [ 3 H]-RP62203 (Fink and Sumner 1996), [ 3 H]ketanserin (Sumner and Fink 1995) and [ 3 H]spiperone (Biegon et al 1983). The present data confirm these results and these changes were paralleled by a similar pattern of changes of 5-HT 2A receptor mRNA levels.…”
Section: Discussionsupporting
confidence: 66%
“…The effect of estradiol to increase 5-HT 2A receptors specific binding of ovariectomized rats was also previously observed using the ligands [ 3 H]-RP62203 (Fink and Sumner 1996), [ 3 H]ketanserin (Sumner and Fink 1995) and [ 3 H]spiperone (Biegon et al 1983). The present data confirm these results and these changes were paralleled by a similar pattern of changes of 5-HT 2A receptor mRNA levels.…”
Section: Discussionsupporting
confidence: 66%
“…Therefore, it can be concluded that the 5-HT 1A receptor subtype is a mediator of the antidepressant-like action of E 2 . Evidences in favor of this hypothesis are the results derived from in vitro and in vivo studies, showing that the 5-HT 1A receptor subtype is a target of estrogens and some estrogen-like compounds (Bethea et al, 1998;Biegon et al, 1983;Mize and Alper, 2000;Mize et al, 2001;Raap et al, 2000;Uphouse, 2000). Indeed, Lu and Bethea (2002) demonstrated that E 2 induces the desensitization of 5-HT 1A receptors in the DRN of monkeys.…”
Section: Discussionmentioning
confidence: 99%
“…On the other hand, in vitro studies demonstrate that estrogens can interact, at several levels, with the dopaminergic, the noradrenergic, and the serotonergic systems (Attali et al, 1997;Bethea et al, 1998;Biegon et al, 1983;Cyr et al, 2000;McEwen, 1999;Rubinow et al, 1998). For example, estrogens can inhibit the function of the monoaminergic transporter (Ghraf et al, 1983;Michel et al, 1987;Wilson et al, 1988) and interact with either 5-HT 1A , 5-HT 2A , or b-adrenergic receptors in several brain areas (Biegon et al, 1983;Fink et al, 1996;Kendall et al, 1982;Mize and Alper, 2000;Ö sterlund et al, 1999;Raap et al, 2000;Sumner and Fink, 1995). Interestingly, estrogenic compounds modify those neurotransmitter systems that are targets of antidepressant treatments.…”
Section: Introductionmentioning
confidence: 99%